Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pharmaceutical Unit Dose Packaging Market Snapshot (2023 to 2033)

The global pharmaceutical unit dose packaging market is expected to attain an impressive valuation of US$ 34.2 billion in 2023 and is projected to reach US$ 136 billion by 2033, expanding at a CAGR of 14.8%.

The thriving growth in pharmaceutical sector is one of the primary growth determinants for inducing pharmaceutical unit dose packaging sales. The pharmaceutical business has been expanding at a rapid pace in recent years due to technological and scientific advancements. This trend is predicted to continue over the forecast period which will positively influence product demand.

The rising desire to decrease drug wastage is further proliferating product sales. Medication waste has a substantial financial impact on the healthcare system which creates negative environmental consequences. For this purpose, adoption of unit dose packaging becomes necessary, which is expected to fuel growth in the market.

Report Attribute Details
Expected Market Value (2023) US$ 34.2 billion
Anticipated Forecast Value (2033) US$ 136 billion
Projected Growth Rate (2023 to 2033) CAGR 14.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Pharmaceutical Unit Dose Packaging Demand Analysis vs. Forecast 2023 to 2033

The market for pharmaceutical unit dose packaging was worth US$ 17.2 billion in 2018. It accumulated a market value of US$ 30 billion in 2022 while growing at a CAGR of 14.9% from 2018 to 2022.

With the advent of new and biosimilar therapies for viral disorders, cancer, and other debilitating diseases, the demand for unit-dose pre-fillable syringes and parental vials is expected to rise in the coming years.

Increasing patient compliance through packaging designs is a major trend supporting market growth. This will promote the use of strip and blister packs, as well as other unit-dose containers. Clinical drug trials are also expected to generate growth opportunities for unit-dose packaging systems that promote compliance and recordkeeping.

Ongoing improvements in syringe design and safety are facilitating therapies meant for self-injection. This is estimated to propel demand for unit-dose parenteral vials and pre-fillable syringes. An increasing focus on infection prevention in parenteral drug delivery systems used in clinics, hospitals, physicians’ offices, and nursing homes will most likely fuel product demand in the next ten years.

Additionally, demand for unit-dose formats will rise in response to the growth of global preventive medicine, which requires single-dose injectable vaccines for diseases like COVID-19, meningitis, influenza, and shingles. After a comprehensive analysis of above-mentioned factors, the revenue growth of pharmaceutical unit dose packaging devices market is projected to be worth US$ 136 billion by end of the forecast period, while exhibiting a CAGR of 14.8%.

Which are Some Prominent Drivers spearheading the Pharmaceutical Unit Dose Packaging devices market?

Introduction of new injectable parenteral therapies to drive the market growth

The expanding healthcare system, increasing per capita income, and heavy investments in drug development are some of the key factors driving the market growth. The growing importance of generic drugs and access to better healthcare services is further expected to boost product sales.

For instance, the 21st Century Cures Act (Cures Act) came into effect on December 13, 2016, in the United States. It is designed to fasten medical product development. The law is expected to generate new innovations in product developments in the pharmaceutical industry. It is estimated to drive the demand for unit dose packaging in the forthcoming years.

Advancements in biotechnology are further expected to drive the growth of primary pharmaceutical packaging like unit dose packaging, resulting in the launch of new injectable parenteral therapies. Moreover, surging demand for high-visibility unit dosage packaging for diseases like diabetes is anticipated to fuel market expansion.

Along with this, the pharmaceutical secondary packaging industry is reflecting significant growth. Due to this, the growth is driven by factors such as rising use of unit dose packaging for drugs, increasing importance of product safety and traceability, and surge in use of child-resistant and senior-friendly packaging.

With the rising use of unit dose packaging for drugs, there is an increased adoption trend of pharmaceutical secondary packaging solutions that can guarantee accurate dosage and minimize the risk of medication errors.

Ismail Sutaria
Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the challenges Projected to be Faced by the Market?

High cost of packaging to restrain market expansion

The growth in the market is expected to be hampered by increasing overall packaging costs as a result of changing regulations and laws. The high installation cost of automated systems and their upkeep costs are further anticipated to hinder market growth.

Region-Wise Insights

What are the growth prospects in North America?

North America to dominate the market with maximum share

North America dominated the market by accumulating a revenue share of 21.2% in 2022. The region is expected to retain this trend by accounting for over 38.6% market share by end of the forecast period.

The presence of several manufacturers of pharmaceutical plastic bottles in the country, including Gerresheimer AG, AptarGroup Inc., Amcor Ltd., and Berry Plastics Group, Inc., is likely to have a positive impact on the demand for single-dose pharmaceutical bottles.

The regional growth is further expected to grow due to thriving economies, a rising geriatric population, and advanced medical delivery systems.

Due to advanced primary medical community, rising research activities in life science and medical science, increasing healthcare spending intensity, and huge presence of pharmaceutical and medical supply and device industries in the region, the product demand is expected to rise.

The United States alone accounted for 11.90% of revenue share in 2022. It is expected to accumulate a 12.8% market share by end of 2023. The region is experiencing strong medication adherence in the correctional setting. The imprisoned population in most correctional facilities depends on outside pharmacies to fill their prescriptions.

Additionally, an onsite pharmacist may be provided in some instances, but such staff is generally restricted, depending on a central location to supply drugs and an onsite nurse manager or similar to dispense. This bolsters the case for dispensing administration systems like unit dose packaging that are low-effort for personnel while yet being able to ensure patient adherence.

What is the growth outlook in China?

China driving growth with significant CAGR

The market in China is expected to grow with a significant CAGR of 6.9% throughout the forecast period. Increasing health awareness among consumers in this region coupled with the inflating disposable income levels is expected to boost the growth of the pharmaceutical industry, thereby directly fuelling demand for unit-dose pharmaceutical packaging.

China dominated the Asia Pacific regional market in 2022 and is expected to retain this trend over the next ten years as well. Factors such as rising government initiatives, such as Healthy China 2020, increasing contract-manufacturing activities, and a burgeoning aging population are anticipated to propel growth in the region’s market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category wise Insights

By Packaging Type, which segment will possess market hegemony?

Vials driving market growth by accumulating maximum share

Vials accounted for a 25.2% share in 2022, on the basis of packaging type. This segment is expected to account for a dominating share by accumulating over 35% share by end of the forecast period. Primary packaging like vials comes in direct contact with the drug which envelopes the drug and prevents it from contamination.

Further, it is often employed for dispensing and dosing drug contents. Packaging companies are concentrating on easy-to-open closures and integration of dispensing systems that deliver the right dose at the right time, which can aid the geriatric population in drug dosage. This aspect is estimated to boost segment growth in the forthcoming period.

By Material Type, which segment is expected to dominate the market?

Plastic to rule the market with maximum share

Plastics & polymers registered a maximum revenue share of 47.5% in 2022. This segment is anticipated to account for 47.9% of revenue share in 2023. Plastic offers a combination of properties, like physical, mechanical, electrical, and thermal characteristics.

Drug formulations generally employ plastic material packaging because it provides safety, reduces breakage, and is easy to manufacture and design.

Compared to glass, Polyethylene maintains a strong protective structure, provides moisture resistance, and can provide weight reduction by up to 90%, making shipping more cost-friendly. The qualities of PET can be further improved using colorants, Oxygen barriers and scavengers, Ultraviolet filters, and other additives to create packaging customized to a particular brand’s needs.

Start-ups in Pharmaceutical Unit Dose Packaging Market

Start-ups help in determining future growth opportunities in any market. These new entrants have the potential to generate high returns which directly benefits the expansion of any industry. These start-ups are typically more productive at transforming inputs into outputs with more flexibility and adaptability in nature, able to shift quickly in response to volatile market conditions. Some of the start-ups that will fuel the expansion of Pharmaceutical Unit Dose Packaging market are

  • MedAvail Technologies provides a digital kiosk for automated medication dispensing. The self-service kiosk solution, the MedAvail MedCenter, helps in giving out prescription drugs and over-the-counter medications. The firm manufactures and designs pharmacist-controlled automated prescription medicine dispensing vaults. It is deemed for use in pharmacies, hospitals, and medical clinics, among others.
  • Hero is a creator of a smart pill dispensing device. It can hold multiple pills and can give out pills as per pre-set schedule. It can also be connected to a smartphone that can track if a pill has been missed and sends reminders and notifies the family members. Some other features are end-of-the-day summaries and multiple user sharing capability.
  • Synapse Medicine offers a virtual assistant for drug prescriptions. The platform provides critical information related to medical errors to telemedicine companies, healthcare professionals, hospitals, healthcare facilities, and other users. It received a total funding of USD 39 million from Korelya Capital, XAnge, MACSF, and 5 Other Investors.

Market Competition

The pharmaceutical unit dose packaging market is extremely competitive and consists of various key industry players. These players are heavily investing in manufacturing unit dose pharmaceutical packaging solutions.

The key industry players are: Gerresheimer AG, West Pharmaceuticals Services, Inc, Schott AG, SGD SA, Stevanato Group S.p.a., Klockner Pentaplast Group, UDG Healthcare plc., Amcor plc., Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Nipro Corporation, Catalent Inc., Becton, Dickinson and Company, Adelphi Healthcare Packaging, Winpak Ltd., Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, AptarGroup, Inc.

Some recent developments in the market are

Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Pharmaceutical Unit Dose Packaging Market.

  • In May 2021, Gerresheimer launched a new platform for on body infusion pump SensAIR that can deliver drugs of high viscosity. It is simple to use and helps in self-determination of medication.
  • In January 2022, Berry Global Group and Raw Elements USA collaborated to introduce a sugarcane-based sustainable tube. The tubes are manufactured from waste sugarcane, which is converted into high-density polyethylene and low-density polyethylene to make a material with the same chemical composition as polyethylene obtained from fossil fuels.
  • In June 2021, Amcor PLC introduced the ACT2100 heat seal coating for use with medical-grade DuPont Tyvek2 and paper packaging. This innovative coating process enhances the performance characteristics of medical applications.

Report Scope

Report Attribute Details
Market Value in 2023 US$ 34.2 billion
Market Value in 2033 US$ 136 billion
Growth Rate CAGR of 14.8% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ billion and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product
  • Material
  • End Use
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa
Key Countries Profiled
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Singapore
  • Thailand
  • Indonesia
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Israel
Key Companies Profiled
  • Gerresheimer AG
  • West Pharmaceuticals Services, Inc.
  • Schott AG
  • SGD SA
  • Stevanato Group S.p.a.
  • Klockner Pentaplast Group
  • UDG Healthcare plc.
  • Amcor plc.
  • Berry Global, Inc.
  • Comar LLC
  • Constantia Flexibles Group GmbH
  • Nipro Corporation
  • Catalent Inc.
  • Becton, Dickinson and Company
  • Adelphi Healthcare Packaging
  • Winpak Ltd.
  • Pacific Vial Manufacturing Inc.
  • Sonoco Products Company
  • WestRock Company
  • AptarGroup, Inc.
Customization Available Upon Request

Key Segments Profiled in the Pharmaceutical Unit Dose Packaging Industry Survey

By Product:

  • Blisters
  • Ampoules
  • Vials
  • Prefilled Syringes & Cartridges

By Material:

  • Plastic
    • Polyethylene
    • Polypropylene
    • Polyvinyl Chloride
    • Polyethylene Terephthalate
  • Aluminium
  • Glass
  • Paper & Paperboard

By End Use:

  • Ophthalmic
  • Injectable
  • Biologics
  • Wound Care
  • Respiratory Therapy
  • Orals

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

What is the anticipated growth of the pharmaceutical unit dose packaging market until 2033?

FMI projects the global pharmaceutical unit dose packaging market to expand at 14.8% value CAGR by 2033.

What is the estimated market value of the pharmaceutical unit dose packaging market expected in 2033?

The global pharmaceutical unit dose packaging market is expected to garner a market value of US$ 136 billion by 2033.

Which region is forecast to be the most lucrative for pharmaceutical unit dose packaging market growth?

FMI has projected China to be one of the most attractive regions for pharmaceutical unit dose packaging market.

Which region is expected to grow with fastest CAGR during the forecast period?

India is anticipated to grow at 7.9% CAGR throughout the forecast period.

By packaging type, which segment is expected to dominate the market by 2033?

Vials is expected to dominate the market by product type during the forecast period

By material type, which segment is most likely to lead the market?

Plastic is projected to lead the market with maximum share by end of the forecast period.

What was the market value of pharmaceutical unit dose packaging in 2018?

The market value of pharmaceutical unit dose packaging was worth US$ 17.2 billion in 2018.

What is the expected market share of Pharmaceutical Unit Dose Packaging devices in North America?

The market in North America is projected to account for 38.6 % market share by end of the forecast period.

Table of Content

1. Executive Summary | Pharmaceutical Unit Dose Packaging Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Blisters

        5.3.2. Ampoules

        5.3.3. Vials

        5.3.4. Prefilled Syringes Cartridges

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2023 to 2033

        6.3.1. Plastic

            6.3.1.1. Polyethylene

            6.3.1.2. Polypropylene

            6.3.1.3. Poly vinyl chloride

            6.3.1.4. Polyethylene Terephthalate

        6.3.2. Aluminium

        6.3.3. Glass

        6.3.4. Paper & Paperboard

    6.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033

7. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033

        7.3.1. Ophthalmic

        7.3.2. Injectable

        7.3.3. Biologics

        7.3.4. Wound Care

        7.3.5. Respiratory Therapy

        7.3.6. Orals

    7.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033

8. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Material

        9.2.4. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Material

        9.3.4. By End Use

    9.4. Key Takeaways

10. Latin America Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Material

        10.2.4. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Material

        10.3.4. By End Use

    10.4. Key Takeaways

11. Europe Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Material

        11.2.4. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Material

        11.3.4. By End Use

    11.4. Key Takeaways

12. Asia Pacific Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Singapore

            12.2.1.5. Thailand

            12.2.1.6. Indonesia

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of Asia Pacific

        12.2.2. By Product

        12.2.3. By Material

        12.2.4. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Material

        12.3.4. By End Use

    12.4. Key Takeaways

13. MEA Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Product

        13.2.3. By Material

        13.2.4. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Material

        13.3.4. By End Use

    13.4. Key Takeaways

14. Key Countries Pharmaceutical Unit Dose Packaging Market Analysis

    14.1. USA

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Product

            14.1.2.2. By Material

            14.1.2.3. By End Use

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Product

            14.2.2.2. By Material

            14.2.2.3. By End Use

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Product

            14.3.2.2. By Material

            14.3.2.3. By End Use

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Product

            14.4.2.2. By Material

            14.4.2.3. By End Use

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Product

            14.5.2.2. By Material

            14.5.2.3. By End Use

    14.6. United kingdom

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Product

            14.6.2.2. By Material

            14.6.2.3. By End Use

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Product

            14.7.2.2. By Material

            14.7.2.3. By End Use

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Product

            14.8.2.2. By Material

            14.8.2.3. By End Use

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Product

            14.9.2.2. By Material

            14.9.2.3. By End Use

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Product

            14.10.2.2. By Material

            14.10.2.3. By End Use

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Product

            14.11.2.2. By Material

            14.11.2.3. By End Use

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Product

            14.12.2.2. By Material

            14.12.2.3. By End Use

    14.13. Singapore

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Product

            14.13.2.2. By Material

            14.13.2.3. By End Use

    14.14. Thailand

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Product

            14.14.2.2. By Material

            14.14.2.3. By End Use

    14.15. Indonesia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Product

            14.15.2.2. By Material

            14.15.2.3. By End Use

    14.16. Australia

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By Product

            14.16.2.2. By Material

            14.16.2.3. By End Use

    14.17. New Zealand

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By Product

            14.17.2.2. By Material

            14.17.2.3. By End Use

    14.18. GCC Countries

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By Product

            14.18.2.2. By Material

            14.18.2.3. By End Use

    14.19. South Africa

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2022

            14.19.2.1. By Product

            14.19.2.2. By Material

            14.19.2.3. By End Use

    14.20. Israel

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2022

            14.20.2.1. By Product

            14.20.2.2. By Material

            14.20.2.3. By End Use

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Product

        15.3.3. By Material

        15.3.4. By End Use

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Gerresheimer AG

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

                16.1.1.5.2. Product Strategy

                16.1.1.5.3. Channel Strategy

        16.1.2. West Pharmaceutical Services, Inc.

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

                16.1.2.5.2. Product Strategy

                16.1.2.5.3. Channel Strategy

        16.1.3. Schott AG

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

                16.1.3.5.2. Product Strategy

                16.1.3.5.3. Channel Strategy

        16.1.4. Stevanato Group S.p.a.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

                16.1.4.5.2. Product Strategy

                16.1.4.5.3. Channel Strategy

        16.1.5. Klockner Pentaplast Group

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

                16.1.5.5.2. Product Strategy

                16.1.5.5.3. Channel Strategy

        16.1.6. Amcor plc

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

                16.1.6.5.2. Product Strategy

                16.1.6.5.3. Channel Strategy

        16.1.7. Berry Global, Inc.

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

                16.1.7.5.2. Product Strategy

                16.1.7.5.3. Channel Strategy

        16.1.8. Constantia Flexibles Group GmbH

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

                16.1.8.5.2. Product Strategy

                16.1.8.5.3. Channel Strategy

        16.1.9. Nipro Corporation

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

                16.1.9.5.2. Product Strategy

                16.1.9.5.3. Channel Strategy

        16.1.10. Becton, Dickinson and Company

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

                16.1.10.5.2. Product Strategy

                16.1.10.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Recommendations

Packaging

Pharmaceutical Packaging Market

Published : April 2024

Packaging

Pharmaceutical Contract Packaging Market

Published : October 2023

Packaging

Anti-counterfeit Pharmaceutical Packaging Market

Published : October 2023

Packaging

Pharmaceutical Packaging Equipment Market

Published : June 2023

Explore Packaging Insights

View Reports

Pharmaceutical Unit Dose Packaging Market